Skip to main navigation
Skip to search
Skip to main content
Bond University Research Portal Home
Help & FAQ
Link opens in a new tab
Search content at Bond University Research Portal
Home
Profiles
Research units
Research Outputs
Student theses
Datasets
Activities
Press/Media
Projects
Biologic agents and tuberculosis
Claudia C. Dobler
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
79
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biologic agents and tuberculosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adalimumab
25%
Bacillus Calmette
25%
Biological Agents
100%
Disease Therapy
25%
High Specificity
25%
Immune Reconstitution
25%
Immune-mediated Inflammatory Diseases
25%
Immunocompromised Patients
25%
Immunosuppressive Therapy
25%
Infection Detection
50%
Infliximab
25%
Inhibitor Treatment
25%
Interferon-gamma Release Assay
75%
Latent Tuberculosis Infection
100%
Mycobacterium Tuberculosis (M. tb)
100%
New Tumor
25%
Optimal Screening
25%
Reintroduction
25%
Relative Risk
25%
Repeated Testing
25%
Screening Algorithm
25%
Screening Program
25%
Screening Test
25%
Single Test
25%
TB Incidence
25%
Tuberculin Skin Test
100%
Tuberculosis Risk
100%
Tumor Necrosis Factor Inhibitor (TNFi)
75%
Tumor Necrosis Factor-α
100%
Vaccination
25%
Immunology and Microbiology
Adalimumab
25%
Biological Product
50%
Immune Reconstitution Inflammatory Syndrome
25%
Immune-Mediated Inflammatory Diseases
25%
Immunosuppressive Therapy
25%
Infection
100%
Infectious Disease
100%
Infliximab
25%
Interferon Gamma
75%
Mantoux Test
100%
Screening Test
25%
TNF Inhibitor
75%
Tumor Necrosis Factor Alpha
100%
Medicine and Dentistry
Adalimumab
7%
Biological Product
15%
Combination Therapy
7%
Immune Reconstitution Inflammatory Syndrome
7%
Immunosuppressive Treatment
7%
Inflammatory Disorder
7%
Infliximab
7%
Interferon Gamma Release Assay
23%
Latent Tuberculosis
7%
Mantoux Test
30%
Screening Test
7%
TNF Inhibitor
23%
Tuberculosis
100%
Tumor Necrosis Factor
30%